Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is Cigna Group the Nation's Best-Run Health Insurance Company?: https://www.marketbeat.com/logos/articles/med_20240525153829_chart-ci.jpg
Is Cigna Group the Nation's Best-Run Health Insurance Company?

Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023. Humana Inc. (NYSE: HUM)

2 Stocks Providing Medical Insurance for Your Pets: https://www.marketbeat.com/logos/articles/med_20240519155501_chart-trup.jpg
2 Stocks Providing Medical Insurance for Your Pets

The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can

CVS Health Stock Has a Silver Lining Called Value: https://www.marketbeat.com/logos/articles/med_20240519153028_chartzy-cvs.jpg
CVS Health Stock Has a Silver Lining Called Value

Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line

Undervalued UnitedHealth Group Won’t Be For Long: https://www.marketbeat.com/logos/articles/med_20240416091545_chart-unh-4162024ver001.png
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Novo Nordisk Arms Wegovy to Be a Triple Threat: https://www.marketbeat.com/logos/articles/med_20240414165029_charts-nvo.jpg
Novo Nordisk Arms Wegovy to Be a Triple Threat

Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label

DexCom Stock Gains from GLP-1 Diabetic Users: https://www.marketbeat.com/logos/articles/med_20240331131923_chart-dxcm.jpg
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?: https://www.marketbeat.com/logos/articles/med_20240304134833_is-unitedhealth-group-stock-a-strong-buy-or-a-fall.jpg
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?

UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024

Can UnitedHealth Group afford to keep Medicare Advantage plans?: https://www.marketbeat.com/logos/articles/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit

Why Cigna stock will be at fresh highs by March: https://www.marketbeat.com/logos/articles/med_20240207143124_why-cigna-stock-will-be-at-fresh-highs-by-march.jpg
Why Cigna stock will be at fresh highs by March

The Cigna Group’s (NYSE: CI) 35% rally that started last summer just hit a new high gear. While investors would have been spooked by the 20% slide from November into December, all that damage has

Is Humana’s pain HCA Healthcare’s gain?: https://www.marketbeat.com/logos/articles/med_20240204124713_chart-hca2.jpg
Is Humana’s pain HCA Healthcare’s gain?

HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including

Med-tech stock Conmed dips ahead of big Q4 report...opportunity?: https://www.marketbeat.com/logos/articles/med_20240129182456_med-tech-stock-conmed-dips-ahead-of-big-q4-report.jpg
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?

When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in

4 med tech stocks with improving prognosis for 2024: https://www.marketbeat.com/logos/articles/med_20240130110415_chart-jnj-1302024ver001.png
4 med tech stocks with improving prognosis for 2024

Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to

Humana EPS shocker. Are Medicare Advantage plans in jeopardy?: https://www.marketbeat.com/logos/articles/med_20240129150334_humana-eps-shocker.jpg
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?

Health insurance carrier Humana Inc. (NYSE: HUM) reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also

5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg
5 top healthcare stocks for earnings growth in 2024

While the healthcare sector delivered lackluster profit growth in 2023, it should change this year. 

Sector components forecast to show the biggest earnings year-over-year earnings improvement

UnitedHealth's rising premiums could cushion stubborn inflation: https://www.marketbeat.com/logos/articles/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg
UnitedHealth's rising premiums could cushion stubborn inflation

When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.

Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

UnitedHealth Group Looks Buyable After AI-Fueled Double Beat: https://www.marketbeat.com/logos/articles/med_20240112120135_unitedhealth-group-looks-buyable-after-ai-fueled-d.jpg
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat

The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on

HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg
HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back. 

Investors

Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_en_PRcom.001.png
Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year

VANCOUVER, British Columbia – December 28, 2023 – Neptune Digital Assets Corp. (TSX-V:NDA) (OTCQB:NPPTF) (FSE:1NW) (“Neptune” or the "Company"), one of the first publicly traded blockchain

Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_de_PRcom.001.png
Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr

VANCOUVER, British Columbia – 28. Dezember 2023 / IRW-Press / – Neptune Digital Assets Corp. (TSX-V: NDA) (OTCQB: NPPTF) (FWB: 1NW) („Neptune“ oder das „Unternehmen“), eines der ersten

Mega merger in the works? Humana, Cigna explore big deal: https://www.marketbeat.com/logos/articles/med_20231201154241_mega-merger-in-the-works-humana-cigna-explore-big.jpg
Mega merger in the works? Humana, Cigna explore big deal

Consolidation in the health insurance industry has become a theme of 2023. Humana Inc. (NYSE: HUM) is reportedly in talks to merge with The Cigna Group (NYSE: CI) in a stock-and-cash deal

BellRing Brands gets pumped on the Ozempic weight-loss trend: https://www.marketbeat.com/logos/articles/med_20231126113844_chart-brbr.jpg
BellRing Brands gets pumped on the Ozempic weight-loss trend

Sports nutritional products maker BellRing Brands Inc. (NYSE: BRBR) has seen its stock surge to new all-time highs driven by the popularity of GLP-1 weight-loss medication usage. While the name of

J&J stock down as business unit mulls talc-related bankruptcy: https://www.marketbeat.com/logos/articles/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg
J&J stock down as business unit mulls talc-related bankruptcy

Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder. 

The Value Deepens for Medtech Stocks: Reversal Imminent: https://www.marketbeat.com/logos/articles/med_20231023085140_chart-bax-10232023ver001.png
The Value Deepens for Medtech Stocks: Reversal Imminent

Results from Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad

Walgreens Boots Alliance: Value or Value Trap?: https://www.marketbeat.com/logos/articles/med_20231012112832_chart-wba-10122023ver001.png
Walgreens Boots Alliance: Value or Value Trap?

Walgreens Boots Alliance (NASDAQ: WBA) shares are down significantly over the past two years and may fall further. The company's turnaround efforts are slowly taking hold, and the impact of